Simplifying Global Compliance
The QMN Weekly Bulletin
Pharmaceuticals / Regulatory Affairs / GMPs
China to Pharma: Stop Foot-Dragging on New Vaccine GMP Certificates
Feb. 14, 2014
In the wake of a rash of infant deaths related to GMP-certified hepatitis B vaccines, China is renewing its push to have makers of vaccines, blood products and sterile injectables obtain a revised good manufacturing practice certificate.
International Pharmaceutical Regulatory Monitor
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing